Regeneron’s Antibody Therapy A Lifesaver In Seronegative COVID-19 Patients

Another Landmark For RECOVERY Trial

 
• By Andrew McConaghie

Identifying patients who have not mounted an immune response to SARS-CoV2 and treating them with the antibody cocktail cuts risk of death by a fifth.

Regeneron
Regeneron will share the data with regulators and seek an expanded EUA in the US

More from Business

More from Scrip